• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种近红外二区光响应的 CoSnO 纳米酶,用于温和光热增强的纳米催化癌症治疗。

An NIR-II-photoresponsive CoSnO nanozyme for mild photothermally augmented nanocatalytic cancer therapy.

机构信息

Department of Health Toxicology, Faculty of Naval Medicine, Naval Medical University, Shanghai, 200433, China.

Operating Theatre, Department of Anaesthesiology, First Affliated Hospital of Naval Medical University, Shanghai, 200433, China.

出版信息

J Mater Chem B. 2024 Jan 17;12(3):710-719. doi: 10.1039/d3tb02018e.

DOI:10.1039/d3tb02018e
PMID:38164065
Abstract

The main challenges of nanozyme-based tumor catalytic therapy (NCT) lie in the unsatisfactory catalytic activity accompanied by a complex tumor microenvironment (TME). A few nanozymes have been designed to possess both enzyme-like catalytic activities and photothermal properties; however, the previously reported nanozymes mainly utilize the inefficient and unsafe NIR-I laser, which has a low maximum permissible exposure limit and a limited penetration depth. Herein, we report for the first time an all-in-one strategy to realize mild NIR-II photothermally amplified NCT by synthesizing amorphous CoSnO nanocubes with efficient triple enzyme-like catalytic activities and photothermal conversion properties. The presence of Co and Sn endows CoSnO nanocubes with the triple enzyme-like catalytic activities, not only achieving enhanced reactive oxygen species (ROS) generation through the Co-mediated peroxidase-like catalytic reaction to generate ˙OH and Sn-mediated depletion of overexpressed GSH, but also realizing the catalytic decomposition of endogenous HO for relieving tumor hypoxia. More importantly, the obtained CoSnO nanocubes with a high photothermal conversion efficiency of 82.1% at 1064 nm could achieve mild hyperthermia (43 °C), which further improves the triple enzyme-like catalytic activities of the CoSnO nanozyme. The synergetic therapeutic efficacy of the NIR-II-responsive CoSnO nanozyme through mild NIR-II PTT-enhanced NCT could realize all-in-one multimodal tumor therapy to completely eliminate tumors without recurrence. This study will open a new avenue to explore NIR-II-photoresponsive nanozymes for efficient tumor therapy.

摘要

基于纳米酶的肿瘤催化治疗(NCT)的主要挑战在于催化活性不理想,同时伴有复杂的肿瘤微环境(TME)。已经设计了一些纳米酶来同时具有酶样催化活性和光热特性;然而,以前报道的纳米酶主要利用低效和不安全的近红外 I 激光,其最大允许暴露限值低,穿透深度有限。在此,我们首次报道了一种通过合成具有高效三酶样催化活性和光热转换特性的非晶态 CoSnO 纳米立方体来实现温和的近红外 II 光热放大 NCT 的一体化策略。Co 和 Sn 的存在赋予了 CoSnO 纳米立方体三酶样催化活性,不仅通过 Co 介导的过氧化物酶样催化反应产生˙OH 和 Sn 介导的过表达 GSH 耗竭来增强活性氧(ROS)的产生,而且实现了内源性 HO 的催化分解以缓解肿瘤缺氧。更重要的是,获得的 CoSnO 纳米立方体在 1064nm 处具有 82.1%的高光热转换效率,可实现温和的热疗(43°C),这进一步提高了 CoSnO 纳米酶的三酶样催化活性。通过温和的近红外 II PTT 增强 NCT 的近红外 II 响应 CoSnO 纳米酶的协同治疗效果,可以实现一体化多模态肿瘤治疗,完全消除肿瘤而不复发。这项研究将为探索用于高效肿瘤治疗的近红外 II 光响应纳米酶开辟新途径。

相似文献

1
An NIR-II-photoresponsive CoSnO nanozyme for mild photothermally augmented nanocatalytic cancer therapy.一种近红外二区光响应的 CoSnO 纳米酶,用于温和光热增强的纳米催化癌症治疗。
J Mater Chem B. 2024 Jan 17;12(3):710-719. doi: 10.1039/d3tb02018e.
2
A Sonoresponsive and NIR-II-Photoresponsive Nanozyme for Heterojunction-Enhanced "Three-in-One" Multimodal Oncotherapy.一种声响应和近红外二区光响应的纳米酶用于异质结增强的“三位一体”多模式肿瘤治疗。
Adv Healthc Mater. 2024 Jan;13(2):e2302190. doi: 10.1002/adhm.202302190. Epub 2023 Oct 15.
3
Cascade enzymatic semiconducting polymer nanocomposites for NIR-II light-mediated photothermal-chemodynamic combinatorial therapy.用于近红外二区光介导光热-化学动力学联合治疗的级联酶促半导体聚合物纳米复合材料
J Mater Chem B. 2025 Jun 25. doi: 10.1039/d5tb01218j.
4
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
2,6-Pyridinedicarboxylic Acid Covalently Bound Polydopamine for Enhanced Tumor Photothermal Therapy in NIR-I and NIR-II.用于近红外一区和近红外二区增强肿瘤光热治疗的2,6-吡啶二甲酸共价结合聚多巴胺
ACS Appl Mater Interfaces. 2025 Jun 18;17(24):35205-35220. doi: 10.1021/acsami.5c05572. Epub 2025 Jun 3.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.肿瘤微环境响应型纳米酶实现了光热增强的肿瘤乏氧多相催化。
Acta Biomater. 2021 Nov;135:617-627. doi: 10.1016/j.actbio.2021.08.015. Epub 2021 Aug 15.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
Removing Barriers to Tumor 'Oxygenation': Depleting Glutathione Nanozymes in Cancer Therapy.消除肿瘤“氧合”障碍:癌症治疗中消耗谷胱甘肽的纳米酶
Int J Nanomedicine. 2025 May 1;20:5613-5643. doi: 10.2147/IJN.S515734. eCollection 2025.